THE SMART TRICK OF FCCP THAT NO ONE IS DISCUSSING

Pregnancy is often a known secondary cause of dyslipidemia, resulting in a potential rise in triglyceride and LDL-C concentrations. Statin therapy is contraindicated through pregnancy resulting in restricted options for dyslipidemia therapy for the duration of pregnancy. Option remedy possibilities are important to treat elevated concentrations du